Carregant...
Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model
Adenocarcinoma accounts for ~40% of lung cancer, equating to ~88,500 new patients in 2015, most of who will succumb to this disease, thus, the public health burden is evident. Unfortunately, few early biomarkers as well as effective therapies exist, hence the need for novel targets in lung cancer tr...
Guardat en:
| Publicat a: | Mol Carcinog |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575741/ https://ncbi.nlm.nih.gov/pubmed/26894620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.22475 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|